← All Sponsors
SPONSOR

Merz Therapeutics GmbH

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Episodic Migraine
NCT07018700 Phase 3
Recruiting

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine

Episodic Migraine
United States, Austria, Czechia View Trial →